U.S. market Closed. Opens in 11 hours 53 minutes

GMED | Globus Medical, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for GMED we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is good and Health is strong.

Valuation (40%)

Company Industry
P/E Ratio (TTM) 230.47 40.66
PEG Ratio (TTM) 11.24 5.42
P/S Ratio (TTM) 4.20 6.33
P/B Ratio (TTM) 2.36 5.87
P/FCF Ratio (TTM) 58.31 37.81
Price to 5YR AVG Earnings Ratio 49.08 59.41
Price to 5YR AVG FCF Ratio 64.72 36.98

Profitability (25%)

Company Industry
ROA (TTM) 0.82% 4.66%
ROE (TTM) 1.01% 25.49%
Net Profit Margin (TTM) 1.82% 7.22%
ROIC 5YR AVG 8.34% 6.54%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 360.25% 2.23% -1.59%
Revenue 23.62% 10.68% 18.43%
Net Income 426.77% 3.65% 0.61%
Cash Flow 26.27% 16.42% 10.06%

Health (63%)

Company Industry
Current Ratio (TTM) 2.42 2.64
Quick Ratio (TTM) 1.45 1.97
D/E Ratio (TTM) 0.13 0.55
Interest Coverage (TTM) 18.62 2.38
Piotroski F-Score 4 6
Altman Z-Score 6.61 7.18
LTL to 5YR AVG FCF 2.88 3.69
Shares Outstanding Growth 5YR AVG 3.04% 1.65%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙